Sharesight release notes – May 2022

by Ben Clendon, Head of Product, Sharesight | Jun 15th 2022

Following strong demand from our US user base, the key highlight for May was adding over 24,000 US mutual funds to our ever-expanding dataset of investments. We also released various UX and usability improvements as noted below.

Sharesight release notes May 2022

UX / Usability improvements

  • Migrated all Macquarie connections to our modernised mobile friendly connections screen
  • Completed a major update of the annual tax components form for Australian ETFs and managed funds
  • Made it easier to add cash accounts to empty portfolios
  • Expanded our new breadcrumbs to additional screens and improved the functionality on both mobile and desktop while also adding a new home icon to all breadcrumbs
  • Modernised the broker page for Marketech
  • Completed an overhaul of the opening balance file import
  • Introduced consistency across all report page headers
  • Updated styling on the portfolio settings page

New Functionality / Enhancements

  • Added support for over 24,000 US mutual funds
  • Expanded benchmarking beyond ETFs, equities and managed funds to include essentially all instruments
  • Added support for the Prague Stock Exchange

Broker Import Functionality (Trade Confirmations and CSV’s)


Sharesight exposure report

See what’s inside your ETFs with Sharesight’s exposure report

by Stephanie Stefanovic | Nov 21st 2023

See inside your ETFs and get the full picture of your investment portfolio's composition with Sharesight's exposure report.

Why KmacD Financial uses Sharesight

How KmacD Financial streamlines reporting and saves time with Sharesight

by Diana Ioppolo | Nov 15th 2023

We talk to financial planning firm KmacD Financial about how the Sharesight-AdviserLogic integration helps them save time and streamline client reporting.

release notes

Sharesight product updates – November 2023

by Ben Clendon | Nov 10th 2023

The focus over the past month has been on implementing additional feature ideas relating to our new (beta) exposure report.